United States Biotechnology & Medical Research

Millendo Therapeutics Inc (MLND)

Track

Millendo Therapeutics Inc. recorded recent insider trading activity on March 24, 2026, when CEO Matthew Angel executed two buy orders. Prior to this, significant divestment occurred in August 2024 via Versant Venture Capital VI, L.P. These transactions represent the latest movements within the firm's equity ownership structure.
Ticker: MLND Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Millendo Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 24 Mar 2026
Value US$1,555,961.67 | Price 227.38 | Shares 29,435 (-2.6%)
Buy 24 Mar 2026
Value US$798,620.70 | Price 437.40 | Shares 22,082 (+20.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-23 2026-03-24 B Purchase
Angel Matthew

CEO and President

Executive Director Large shareholder
29,435 -2.6%
227.38
US$1,555,962 		29,435 -2.6% 227.38 US$1,555,962
2026-03-25 2026-03-24 B Purchase
Angel Matthew

CEO and President

Executive Director Large shareholder
22,082 +20.4%
437.40
US$798,621 		22,082 +20.4% 437.40 US$798,621
2024-08-13 2024-08-12 PrS Proposed sale
3.5
Versant Venture Capital VI, L.P.

Owner
21,864
276.98
US$3,005,626 		21,864 276.98 US$3,005,626
2024-08-12 2024-08-12 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
387,999 -64.9%
1.10
US$426,993 		387,999 -64.9% 1.10 US$426,993
2024-08-12 2024-08-08 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
400,000 -40.1%
1.35
US$540,040 		400,000 -40.1% 1.35 US$540,040
2024-08-09 2024-08-08 PrS Proposed sale
3.5
Versant Venture Capital VI, L.P.

10% Stockholder

Large shareholder
400,000
18.03
US$7,210,532 		400,000 18.03 US$7,210,532
2024-07-08 2024-07-03 B Purchase
Brady Stephen R

President and CEO

Executive Director
35,000 +307.7%
2.11
US$73,850 		35,000 +307.7% 2.11 US$73,850
2024-07-03 2024-07-02 B Purchase
Whiting Samuel

Chief Medical Officer

Officer
4,672 +95.3%
2.13
US$9,951 		4,672 +95.3% 2.13 US$9,951
2024-07-02 2024-06-28 B Purchase
Trojanowski Justin

Corporate Controller

Officer
7,500 +51.1%
2.16
US$16,200 		7,500 +51.1% 2.16 US$16,200
2023-11-02 2023-10-25 PrS Proposed sale
Dubensky Thomas W.

Officer; Director

Executive Director
30,000
4.38
US$131,452 		30,000 4.38 US$131,452
2022-05-03 2022-04-29 B Purchase
3.8
Woiwode Thomas
Non-Executive Director Large shareholder
2,118,644 +inf%
2.36
US$5,000,000 		2,118,644 +inf% 2.36 US$5,000,000
2022-01-11 2022-01-07 B Purchase
Dubensky Thomas W.

President

Executive Director
2,000 +1.8%
4.78
US$9,560 		2,000 +1.8% 4.78 US$9,560
2022-01-10 2022-01-06 B Purchase
Whiting Samuel

Chief Medical Officer

Officer
1,700 +845.8%
4.80
US$8,168 		1,700 +845.8% 4.80 US$8,168
2016-06-03 2016-06-01 B Purchase ALDRICH RICHARD Non-Executive Director
425,000 +79.1%
7.00
US$2,975,000 		425,000 +79.1% 7.00 US$2,975,000
2016-06-03 2016-06-01 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
425,000 +79.1%
7.00
US$2,975,000 		425,000 +79.1% 7.00 US$2,975,000
2016-05-20 2016-05-18 B Purchase ALDRICH RICHARD Non-Executive Director
20,000 +3.9%
7.86
US$157,200 		20,000 +3.9% 7.86 US$157,200
2016-05-20 2016-05-18 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
20,000 +3.9%
7.86
US$157,200 		20,000 +3.9% 7.86 US$157,200
2016-05-18 2016-05-17 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
20,000 +4.0%
7.56
US$151,200 		20,000 +4.0% 7.56 US$151,200
2016-05-18 2016-05-17 B Purchase ALDRICH RICHARD Non-Executive Director
20,000 +4.0%
7.56
US$151,200 		20,000 +4.0% 7.56 US$151,200
2016-05-18 2016-05-16 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
20,000 +4.2%
7.69
US$153,800 		20,000 +4.2% 7.69 US$153,800
2016-05-16 2016-05-13 B Purchase ALDRICH RICHARD Non-Executive Director
16,295 +3.5%
7.06
US$115,043 		16,295 +3.5% 7.06 US$115,043
2016-05-16 2016-05-13 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
16,295 +3.5%
7.06
US$115,043 		16,295 +3.5% 7.06 US$115,043
2016-05-16 2016-05-12 B Purchase ALDRICH RICHARD Non-Executive Director
5,600 +1.2%
7.13
US$39,928 		5,600 +1.2% 7.13 US$39,928
2016-05-16 2016-05-12 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
5,600 +1.2%
7.13
US$39,928 		5,600 +1.2% 7.13 US$39,928
2016-05-16 2016-05-12 B Purchase ALDRICH RICHARD Non-Executive Director
14,200 +3.2%
6.72
US$95,424 		14,200 +3.2% 6.72 US$95,424
2016-05-16 2016-05-12 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
14,200 +3.2%
6.72
US$95,424 		14,200 +3.2% 6.72 US$95,424
2016-05-13 2016-05-11 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
20,000 +4.8%
7.64
US$152,800 		20,000 +4.8% 7.64 US$152,800
2016-05-13 2016-05-11 B Purchase ALDRICH RICHARD Non-Executive Director
20,000 +4.8%
7.64
US$152,800 		20,000 +4.8% 7.64 US$152,800
2016-05-12 2016-05-10 B Purchase CHAPMAN PAUL W.D.

Chief Operating Officer

Officer
3,100 +inf%
7.37
US$22,847 		3,100 +inf% 7.37 US$22,847
2016-05-12 2016-05-10 B Purchase ALDRICH RICHARD Non-Executive Director
19,900 +5.0%
7.72
US$153,628 		19,900 +5.0% 7.72 US$153,628
2016-05-12 2016-05-10 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
19,900 +5.0%
7.72
US$153,628 		19,900 +5.0% 7.72 US$153,628
2016-03-25 2016-03-24 B Purchase ALDRICH RICHARD Non-Executive Director
30,000 +8.1%
9.23
US$276,906 		30,000 +8.1% 9.23 US$276,906
2016-03-25 2016-03-24 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
30,000 +8.1%
9.23
US$276,906 		30,000 +8.1% 9.23 US$276,906
2016-03-25 2016-03-23 B Purchase ALDRICH RICHARD Non-Executive Director
8,100 +2.2%
10.18
US$82,483 		8,100 +2.2% 10.18 US$82,483
2016-03-25 2016-03-23 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
8,100 +2.2%
10.18
US$82,483 		8,100 +2.2% 10.18 US$82,483
2016-03-25 2016-03-23 B Purchase ALDRICH RICHARD Non-Executive Director
21,700 +6.4%
9.58
US$207,851 		21,700 +6.4% 9.58 US$207,851
2016-03-25 2016-03-23 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
21,700 +6.4%
9.58
US$207,851 		21,700 +6.4% 9.58 US$207,851
2016-03-23 2016-03-22 B Purchase ALDRICH RICHARD Non-Executive Director
29,800 +9.6%
10.53
US$313,922 		29,800 +9.6% 10.53 US$313,922
2016-03-23 2016-03-22 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
29,800 +9.6%
10.53
US$313,922 		29,800 +9.6% 10.53 US$313,922
2016-03-23 2016-03-21 B Purchase ALDRICH RICHARD Non-Executive Director
21,100 +7.3%
10.71
US$225,884 		21,100 +7.3% 10.71 US$225,884
2016-03-23 2016-03-21 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
21,100 +7.3%
10.71
US$225,884 		21,100 +7.3% 10.71 US$225,884
2016-03-23 2016-03-21 B Purchase ALDRICH RICHARD Non-Executive Director
8,900 +3.2%
9.52
US$84,708 		8,900 +3.2% 9.52 US$84,708
2016-03-23 2016-03-21 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
8,900 +3.2%
9.52
US$84,708 		8,900 +3.2% 9.52 US$84,708
2016-03-21 2016-03-18 B Purchase ALDRICH RICHARD Non-Executive Director
29,900 +11.9%
8.72
US$260,743 		29,900 +11.9% 8.72 US$260,743
2016-03-21 2016-03-18 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
29,900 +11.9%
8.72
US$260,743 		29,900 +11.9% 8.72 US$260,743
2016-03-21 2016-03-17 B Purchase ALDRICH RICHARD Non-Executive Director
29,800 +13.4%
7.79
US$232,219 		29,800 +13.4% 7.79 US$232,219
2016-03-21 2016-03-17 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
29,800 +13.4%
7.79
US$232,219 		29,800 +13.4% 7.79 US$232,219
2016-03-17 2016-03-16 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
7,800 +3.6%
8.13
US$63,381 		7,800 +3.6% 8.13 US$63,381
2016-03-17 2016-03-16 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
21,729 +11.3%
7.59
US$164,921 		21,729 +11.3% 7.59 US$164,921
2016-03-17 2016-03-16 B Purchase ALDRICH RICHARD Non-Executive Director
7,800 +3.6%
8.13
US$63,381 		7,800 +3.6% 8.13 US$63,381
2016-03-17 2016-03-16 B Purchase ALDRICH RICHARD Non-Executive Director
21,729 +11.3%
7.59
US$164,921 		21,729 +11.3% 7.59 US$164,921
2016-03-17 2016-03-15 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
11,900 +6.6%
8.44
US$100,462 		11,900 +6.6% 8.44 US$100,462
2016-03-17 2016-03-15 B Purchase ALDRICH RICHARD Non-Executive Director
11,900 +6.6%
8.44
US$100,462 		11,900 +6.6% 8.44 US$100,462
2016-03-17 2016-03-15 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
17,600 +10.8%
7.80
US$137,340 		17,600 +10.8% 7.80 US$137,340
2016-03-17 2016-03-15 B Purchase ALDRICH RICHARD Non-Executive Director
17,600 +10.8%
7.80
US$137,340 		17,600 +10.8% 7.80 US$137,340
2016-03-15 2016-03-14 B Purchase ALDRICH RICHARD Non-Executive Director
30,000 +22.6%
8.05
US$241,602 		30,000 +22.6% 8.05 US$241,602
2016-03-15 2016-03-14 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
30,000 +22.6%
8.05
US$241,602 		30,000 +22.6% 8.05 US$241,602
2016-03-15 2016-03-11 B Purchase ALDRICH RICHARD Non-Executive Director
132,732 +inf%
7.50
US$995,490 		132,732 +inf% 7.50 US$995,490
2016-03-15 2016-03-11 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
132,732 +inf%
7.50
US$995,490 		132,732 +inf% 7.50 US$995,490
2015-10-07 2015-10-05 B Purchase Young Jeffrey E

Chief Financial Officer

Officer
3,450 +1150.0%
10.70
US$36,915 		3,450 +1150.0% 10.70 US$36,915
2015-10-06 2015-10-05 B Purchase KOZIN MARC D Non-Executive Director
4,800 +30.5%
10.79
US$51,792 		4,800 +30.5% 10.79 US$51,792
2015-09-11 2015-09-09 B Purchase FISHER MARY Non-Executive Director
6,100 +1936.5%
16.49
US$100,589 		6,100 +1936.5% 16.49 US$100,589
2015-09-10 2015-09-08 B Purchase KOZIN MARC D Non-Executive Director
3,000 +25.8%
17.60
US$52,800 		3,000 +25.8% 17.60 US$52,800
2016-05-18 2015-05-16 B Purchase ALDRICH RICHARD Non-Executive Director
20,000 +4.2%
7.69
US$153,800 		20,000 +4.2% 7.69 US$153,800
2015-04-09 2015-04-09 B Purchase McNeely Theresa

EVP, Chief Comm. Officer

Officer
226 +129.9%
29.68
US$6,708 		226 +129.9% 29.68 US$6,708
2015-04-09 2015-04-09 B Purchase TZIANABOS ARTHUR

President and CSO

Officer
225 +128.6%
28.77
US$6,473 		225 +128.6% 28.77 US$6,473
2015-04-09 2015-04-08 B Purchase ALDRICH RICHARD Non-Executive Director
2,500 +12.6%
29.97
US$74,925 		2,500 +12.6% 29.97 US$74,925
2015-04-09 2015-04-08 B Purchase Young Jeffrey E

Chief Financial Officer

Officer
300 +inf%
29.93
US$8,979 		300 +inf% 29.93 US$8,979
2015-04-09 2015-04-08 B Purchase McNeely Theresa

EVP, Chief Comm. Officer

Officer
174 +inf%
28.79
US$5,009 		174 +inf% 28.79 US$5,009
2015-04-09 2015-04-08 B Purchase KOZIN MARC D Non-Executive Director
3,000 +36.2%
28.45
US$85,350 		3,000 +36.2% 28.45 US$85,350
2015-04-09 2015-04-08 B Purchase Malley Thomas Non-Executive Director
5,000 +4.3%
28.50
US$142,500 		5,000 +4.3% 28.50 US$142,500
2015-04-08 2015-04-08 B Purchase TZIANABOS ARTHUR

President and CSO

Officer
175 +inf%
28.04
US$4,907 		175 +inf% 28.04 US$4,907
2015-04-02 2015-04-02 B Purchase Dipp Michelle

Chief Executive Officer

Executive Director
1,000 +0.1%
32.49
US$32,490 		1,000 +0.1% 32.49 US$32,490
2015-01-15 2015-01-13 B Purchase Malley Thomas Non-Executive Director
35,000 +42.8%
50.00
US$1,750,000 		35,000 +42.8% 50.00 US$1,750,000
2015-04-14 2014-04-10 B Purchase Harding David

Chief Commercial Officer

Officer
1,000 +77.5%
32.23
US$32,230 		1,000 +77.5% 32.23 US$32,230
Explore more

More insider trading research around Millendo Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America